KEYNOTE Chief Executive
Dr Katharine Giles has dedicated her career to improving the health and wellbeing of patients and their families through the development and application of novel technologies and is a passionate advocate for Western Australian innovation. Katharine is currently Managing Director and CEO of OncoRes Medical, a Perth-based company focused on improving the accuracy of breast cancer surgery and eliminating the physical, psychological and economic burdens associated with repeat operations. Katharine is a Venture Partner at Brandon Capital Partners, a venture capital firm devoted to developing and supporting Australian life sciences businesses, a Director of Respirion Pharmaceuticals and a member of the Curtin Commercialisation Advisory Board.
